# Addition of Spironolactone in Patients With Resistant Arterial Hypertension

> **NCT00524615** · PHASE4 · UNKNOWN · sponsor: **Jan Vaclavík** · enrollment: 160 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** spironolactone

## Key facts

- **NCT ID:** NCT00524615
- **Lead sponsor:** Jan Vaclavík
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2012-06-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524615, "Addition of Spironolactone in Patients With Resistant Arterial Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00524615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*